Policy & Medicine

Legislation Aimed at CMMI Equity Model Introduced in Congress

Thomas Sullivan Jul 1, 2022 0

In May 2022, United States Representative Terri Sewell introduced The John Lewis Equality in Medicare and Medicaid Treatment Act, legislation aimed at advancing equity in the work of the Center for Medicare and Medicaid Innovation (CMMI). Currently, CMMI is not required to consider social determinants of health – including a patient’s…

Policy and Medicine Compliance Update – June 2022 Issue:…

Thomas Sullivan Jun 24, 2022 0

Policy and Medicine Compliance Update April 2022 Issue…

Thomas Sullivan Apr 23, 2022 0

Legislation Aimed at CMMI Equity Model Introduced in Congress

Transparency, Aggregate Spend & HCP Engagement 2022 Hybrid…

The Transparency, Aggregate Spend & HCP Engagement 2022 is scheduled as a hybrid event, with the in-person portion happening August 9-11, 2022, at the Ritz-Carlton Tysons Corner in McLean, VA and…

AHA Asks for Investigation Into MA Organizations Over Prior…

The American Hospital Association has asked the Department of Justice (DOJ) and Centers for Medicare & Medicaid Services (CMS) to look into commercial payers that routinely deny access to care and…

California Senate Passes Legislation to Require CME for…

Recently, the California Senate passed Senate Bill 923, the TGI Inclusive Care Act, by a vote of 28-6. The legislation – the first of its kind in the nation – attempts to create a “more inclusive and…

FDA Launches Educational Initiative About Supplements

On June 2, 2022, the United States Food and Drug Administration (FDA) announced a new initiative, Supplement Your Knowledge. The goal of the initiative is to “educate, inform, and broaden consumer,…

Connecticut to Establish a Permanent Rare Disease Advisory…

In May 2022, Connecticut Governor Ned Lamont signed House Bill 5500 into law, which will help establish a permanent Rare Disease Advisory Council (RDAC) in the state. This follows-up on the temporary…

Policy and Medicine Compliance Update – June 2022 Issue:…

Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth in issues and stay up to date on the latest trends. We encourage you…

Translating Clinical Research to Clinical Care in Nephrology

Recently, CMEology conducted a study of nephrologists to identify factors that are influential in the translation of research findings into clinical care for patients with autosomal dominant…

Legislation Focused on Revamping MA Prior Authorization Hits…

In mid-May 2022, H.R. 3173, the Improving Seniors’ Timely Access to Care Act of 2021 surpassed the 290-cosponsor threshold needed to include the legislation on the House Consensus Calendar. If passed,…

Attention on March-In Rights – What Are They and Why are they…

March-in rights are rights granted to the federal government, allowing the government the ability to grant patent licenses to other parties or take licenses for themselves if they helped to fund the…

DaVita and Former CEO Acquitted on Conspiracy Charges

Earlier this year, a Colorado jury acquitted DaVita and its former CEO Kent Thiry on charges that they conspired with competitors to not hire each other’s employees. The Department of Justice (DOJ)…

OPDP to Study Product Claims in DTC and HCP Promotions

Earlier this year, the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) published a notice in the Federal Register about a study it expects to conduct…